Your browser doesn't support javascript.
loading
Voltage Imaging of Cardiac Cells and Tissue Using the Genetically Encoded Voltage Sensor Archon1.
Shroff, Sanaya N; Das, Shoshana L; Tseng, Hua-An; Noueihed, Jad; Fernandez, Fernando; White, John A; Chen, Christopher S; Han, Xue.
Afiliação
  • Shroff SN; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
  • Das SL; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA; Harvard-MIT Program in Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Wyss Institute for Biologically Inspired Engineering,
  • Tseng HA; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
  • Noueihed J; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
  • Fernandez F; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
  • White JA; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA.
  • Chen CS; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA. Electronic address: chencs@bu.edu.
  • Han X; Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA. Electronic address: xuehan@bu.edu.
iScience ; 23(4): 100974, 2020 Apr 24.
Article em En | MEDLINE | ID: mdl-32299055
ABSTRACT
Precise measurement of action potentials (APs) is needed to observe electrical activity and cellular communication within cardiac tissue. Voltage-sensitive dyes (VSDs) are traditionally used to measure cardiac APs; however, they require acute chemical addition that prevents chronic imaging. Genetically encoded voltage indicators (GEVIs) enable long-term studies of APs without the need of chemical additions, but current GEVIs used in cardiac tissue exhibit poor kinetics and/or low signal to noise (SNR). Here, we demonstrate the use of Archon1, a recently developed GEVI, in hiPSC-derived cardiomyocytes (CMs). When expressed in CMs, Archon1 demonstrated fast kinetics comparable with patch-clamp electrophysiology and high SNR significantly greater than the VSD Di-8-ANEPPS. Additionally, Archon1 enabled monitoring of APs across multiple cells simultaneously in 3D cardiac tissues. These results highlight Archon1's capability to investigate the electrical activity of CMs in a variety of applications and its potential to probe functionally complex in vitro models, as well as in vivo systems.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: IScience Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos